Mark Gray-Keller
10Patents
3h-index
15Co-inventors
53Inventor score
Filing activity: Nov 1, 2000 → Nov 24, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7390813B1 | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents | Human Necessities | 18 | Expired |
| US7790408B1 | Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents | Physics | 7 | Active |
| US6987001B2 | Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents | Physics | 3 | Expired |
| US7166584B1 | Cholesterol transport gene | Physics | 1 | Expired |
| US7696151B2 | Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents | Physics | 0 | Active |
| US7863301B2 | Potentiators of insulin secretion | Physics | 0 | Expired |
| US8507557B2 | Potentiators of insulin secretion | Physics | 0 | Active |
| US7816075B2 | Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents | Physics | 0 | Active |
| US6759208B2 | High throughput screening assays using fatty acid synthetic enzymes | Physics | 0 | Expired |
| US7294480B2 | High throughput screening assays using fatty acid synthetic enzymes | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.